Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Ten patients with prostatic carcinoma--six with stage C and four with stage D disease--were treated for 6 weeks to 12 months with agonistic analogues of luteinizing hormone-releasing hormone (LH-RH). [D-Trp6]LH-RH was given subcutaneously once daily at a dose of 100 microgram and [D-Ser(But)6]des-Gl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tolis, G, Ackman, D, Stellos, A, Mehta, A, Labrie, F, Fazekas, A T, Comaru-Schally, A M, Schally, A V
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1982
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC346035/
https://ncbi.nlm.nih.gov/pubmed/6461861
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller